Understand the source comparison
DSIP Insomnia Mechanism — Comparison Across Sleep Interventions
DSIP (delta sleep-inducing peptide) 30–60 minutes Increases slow-wave sleep (stages 3–4) by 20–30%; preserves REM cycles; no suppression of natural sleep stages None observed after 12 weeks nightly use Minimal to none. Reaction time unaffected at 8 hours post
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- DSIP (delta sleep-inducing peptide)
- 30–60 minutes
- Increases slow-wave sleep (stages 3–4) by 20–30%; preserves REM cycles; no suppression of natural sleep stages
- None observed after 12 weeks nightly use
- Minimal to none. Reaction time unaffected at 8 hours post-administration
- Chronic insomnia, shift-work sleep disorder, stress-related sleep disruption, circadian phase delay
- Benzodiazepines (lorazepam, temazepam)
- 15–30 minutes
- Suppresses slow-wave sleep by 30–50%; reduces REM sleep by 20–35%; fragments sleep architecture
- Develops within 2–4 weeks; dose escalation required
- Significant. Cognitive impairment, motor slowing, rebound anxiety persist 12–18 hours
- Short-term insomnia only (max 2–4 weeks); not suitable for chronic use
- Z-drugs (zolpidem, eszopiclone)
- 20–40 minutes
- Moderate suppression of slow-wave sleep (15–25%); less REM disruption than benzodiazepines but still present
- Develops within 4–8 weeks; psychological dependence common
- Moderate. 'hangover effect', amnesia, complex sleep behaviours (sleepwalking, sleep-driving)
- Short-term insomnia; slightly better profile than benzodiazepines but still dependency risk
- Antihistamines (diphenhydramine, doxylamine)
- No increase in restorative sleep; may reduce REM percentage; does not address underlying dysregulation
- Develops rapidly (within 3–5 days); efficacy drops to placebo level
- Severe. Next-day sedation, cognitive fog, anticholinergic effects (dry mouth, confusion in elderly)
- Not recommended for chronic insomnia; anticholinergic burden makes it unsuitable for regular use
- Melatonin
- 60–90 minutes
- Minimal effect on sleep architecture; primarily shifts circadian phase rather than inducing sleep
- None
- None. Well-tolerated with no hangover
- Circadian phase disorders (jet lag, delayed sleep phase); ineffective for sleep maintenance insomnia
- Professional Assessment
- DSIP is the only intervention in this table that increases slow-wave sleep without suppressing REM or producing tolerance. Its mechanism targets the underlying dysregulation rather than forcing sedation. Benzodiazepines and Z-drugs are appropriate only for acute, short-term insomnia and carry significant dependency and cognitive risk. Antihistamines should not be used for insomnia management. The anticholinergic burden and rapid tolerance make them ineffective and potentially harmful, particularly in older adults. Melatonin is a phase-shifter, not a hypnotic. Useful for circadian misalignment but not for sleep initiation or maintenance.